All Stories

  1. Improving the Utilization of Deceased Donor Kidneys by Prioritizing Patient Preferences
  2. Variations in Deceased Donor Terminal Creatinine Values Reported in the OPTN Data Registry
  3. COVID-19–Associated Mortality among Kidney Transplant Recipients and Candidates in the United States
  4. Managing Patients with Failing Kidney Allograft
  5. Major Variation across Local Transplant Centers in Probability of Kidney Transplant for Wait-Listed Patients
  6. Kidney non‐procurement in solid organ donors in the United States
  7. COVID‐19 in Solid Organ Transplant Recipients: Initial Report from the US Epicenter
  8. Early Description of Coronavirus 2019 Disease in Kidney Transplant Recipients in New York
  9. Pilot Study of Return of Genetic Results to Patients in Adult Nephrology
  10. Creatinine versus cystatin C for renal function-based mortality prediction in an elderly cohort: The Northern Manhattan Study
  11. Geographic Variation in the Availability of Deceased Donor Kidneys per Wait-Listed Candidate in the United States
  12. Evaluation of kidney allocation critical data validity in the OPTN registry using dialysis dates
  13. A Donor Utilization Index to Assess the Utilization and Discard of Deceased Donor Kidneys Perceived as High Risk
  14. Trends in Disparities in Preemptive Kidney Transplantation in the United States
  15. National Trends in Utilization and 1-Year Outcomes with Transplantation of HCV-Viremic Kidneys
  16. Regional Disparities in Transplantation With Deceased Donor Kidneys With Kidney Donor Profile Index Less Than 20% Among Candidates With Top 20% Estimated Post Transplant Survival
  17. Patient-Centered Outcomes with Second Kidney Transplant
  18. A Focus on APOL1 and Kidney Disease
  19. Cultural barriers to organ donation among Chinese and Korean individuals in the United States: a systematic review
  20. Genomic Mismatch at LIMS1 Locus and Kidney Allograft Rejection
  21. Health-related quality of life in glomerular disease
  22. Deceased Donor Kidneys Are Harder to Place on the Weekend
  23. APOL1 Genetic Testing in Living Kidney Transplant Donors
  24. Quality Metrics in Kidney Transplantation: Current Landscape, Trials and Tribulations, Lessons Learned, and a Call for Reform
  25. Outcomes of kidney transplant from deceased donors with acute kidney injury and prolonged cold ischemia time - a retrospective cohort study
  26. Lack of Benefit and Potential Harm of Induction Therapy in Simultaneous Liver-Kidney Transplants
  27. CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease
  28. Diagnostic Utility of Exome Sequencing for Kidney Disease
  29. Deceased-donor acute kidney injury is not associated with kidney allograft failure
  30. KI Reports in 2019: Further Expanding Access to Research in Nephrology
  31. Donor’s APOL1 Risk Genotype and “Second Hits” Associated With De Novo Collapsing Glomerulopathy in Deceased Donor Kidney Transplant Recipients: A Report of 5 Cases
  32. Using technology to enhance medication regimen education after solid organ transplantation
  33. Donor APOL1 high-risk genotypes are associated with increased risk and inferior prognosis of de novo collapsing glomerulopathy in renal allografts
  34. Creatinine- versus cystatin C-based renal function assessment in the Northern Manhattan Study
  35. Outcomes for potential kidney transplant recipients offered public health service increased risk kidneys: A single-center experience
  36. Deceased brain dead donor liver transplantation and utilization in the United States
  37. Clinical Characteristics and Treatment Patterns of Children and Adults With IgA Nephropathy or IgA Vasculitis: Findings From the CureGN Study
  38. Association between the “Timed Up and Go Test” at transplant evaluation and outcomes after kidney transplantation
  39. Procurement Biopsies in the Evaluation of Deceased Donor Kidneys
  40. Report of National Kidney Foundation Consensus Conference to Decrease Kidney Discards
  41. Current opinions in organ allocation
  42. Kidney transplant offers to deceased candidates
  43. Patients prioritize waitlist over posttransplant outcomes when evaluating kidney transplant centers
  44. Factors leading to the discard of deceased donor kidneys in the United States
  45. Expanding transplant outcomes research opportunities through the use of a common data model
  46. Analysis of dendritic cells and ischemia-reperfusion changes in postimplantation renal allograft biopsies may serve as predictors of subsequent rejection episodes
  47. Induction regimen and survival in simultaneous heart-kidney transplant recipients
  48. Kidney International Reports : Two Years of Publication
  49. Racial/ethnic disparities in waitlisting for deceased donor kidney transplantation 1 year after implementation of the new national kidney allocation system
  50. Awareness of Racial Disparities in Kidney Transplantation among Health Care Providers in Dialysis Facilities
  51. Effect of the iChoose Kidney decision aid in improving knowledge about treatment options among transplant candidates: A randomized controlled trial
  52. Standardized Transplantation Referral Ratio to Assess Performance of Transplant Referral among Dialysis Facilities
  53. Awareness of the New Kidney Allocation System among United States Dialysis Providers with Low Waitlisting
  54. Emergency department use among kidney transplant recipients in the United States
  55. Characteristics and Performance of Unilateral Kidney Transplants from Deceased Donors
  56. Relation of Coronary Flow Reserve to Other Findings on Positron Emission Tomography Myocardial Perfusion Imaging and Left Heart Catheterization in Patients With End-stage Renal Disease Being Evaluated for Kidney Transplant
  57. Achieving Equity through Reducing Variability in Accepting Deceased Donor Kidney Offers
  58. Association between Reperfusion Renal Allograft Biopsy Findings and Transplant Outcomes
  59. Kidney International Reports : The First Year
  60. Predictive Value of Using Initial Versus Terminal Deceased Donor Creatinine to Calculate the Kidney Donor Risk Index
  61. Acute Kidney Injury Recognition in Low- and Middle-Income Countries
  62. New Kidney Allocation System Associated With Increased Rates Of Transplants Among Black And Hispanic Patients
  63. Decisional conflict between treatment options among end-stage renal disease patients evaluated for kidney transplantation
  64. The Reply
  65. United States Dialysis Facilities With a Racial Disparity in Kidney Transplant Waitlisting
  66. Coronary Plaque Characteristics in Hemodialysis-Dependent Patients as Assessed by Optical Coherence Tomography
  67. The ASCENT (Allocation System Changes for Equity in Kidney Transplantation) Study: A Randomized Effectiveness-Implementation Study to Improve Kidney Transplant Waitlisting and Reduce Racial Disparity
  68. KI Reports and World Kidney Day
  69. Sense and sensitivity: incompatible patients and their donors in kidney transplantation
  70. Combined Percutaneous Transrenal and Transfemoral Endovascular Recanalization and Angioplastic Reconstruction of a Disrupted Transplant Renal Artery Stent: A Novel Salvage Technique
  71. Effect of Replacing Race With Apolipoprotein L1 Genotype in Calculation of Kidney Donor Risk Index
  72. Association of Weight Perception, Race and Readiness to Quit Smoking amongst a Cohort of Workers
  73. Incidence of Hyponatremia with High-Dose Trimethoprim-Sulfamethoxazole Exposure
  74. Simultaneous Liver-Kidney Transplantation in Liver Transplant Candidates With Renal Dysfunction: Importance of Creatinine Levels, Dialysis, and Organ Quality in Survival
  75. Emergency Department Use and Hospital Admissions Among Patients With End-Stage Renal Disease in the United States
  76. Diagnosis and Management of Cardiovascular Disease in Advanced and End‐Stage Renal Disease
  77. The weekend effect alters the procurement and discard rates of deceased donor kidneys in the United States
  78. Rejection and graft outcomes based on induction agents in deceased donort transplantation
  79. A Randomized Controlled Trial of a Mobile Clinical Decision Aid to Improve Access to Kidney Transplantation: iChoose Kidney
  80. iChoose Kidney
  81. Applications for Detection of Acute Kidney Injury Using Electronic Medical Records and Clinical Information Systems: Workgroup Statements from the 15th ADQI Consensus Conference
  82. Pre-ESRD Care and Mortality in Incident ESRD Patients With Multiple Myeloma
  83. APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors
  84. Electrolyte and Acid–Base Disturbances in Diabetes Mellitus
  85. One Size Does Not Fit All—Regional Variation in the Impact of the Share 35 Liver Allocation Policy
  86. Nonalbumin proteinuria predominates in biopsy-proven tenofovir nephrotoxicity
  87. The Authors Reply
  88. Apolipoprotein L1 Gene Variants in Deceased Organ Donors Are Associated With Renal Allograft Failure
  89. Racial and ethnic disparities in pediatric renal allograft survival in the United States
  90. Integrating Real Time Data to Improve Outcomes in Acute Kidney Injury
  91. α–Intercalated cells defend the urinary system from bacterial infection
  92. Presence of early CKD-related metabolic complications predict progression of stage 3 CKD: a case-controlled study
  93. Kidney Transplantation and the Intensity of Poverty in the Contiguous United States
  94. The Authors’ Reply
  95. α–Intercalated cells defend the urinary system from bacterial infection
  96. Risk evaluation and mitigation strategy programs in solid organ transplantation: the promises of information technology
  97. Kidneys at Higher Risk of Discard: Expanding the Role of Dual Kidney Transplantation
  98. Recovery of Renal Function among ESRD Patients in the US Medicare Program
  99. Prevalence of Hyponatremia and Association with Mortality: Results from NHANES
  100. Trimethoprim-Associated Hyponatremia
  101. Preformed Donor-Specific Antibodies and Risk of Antibody-Mediated Rejection in Repeat Renal Transplantation
  102. Risk factors associated withClostridium difficileinfection after kidney and pancreas transplantation
  103. Future of Medicare Immunosuppressive Drug Coverage for Kidney Transplant Recipients in the United States
  104. The changing pattern of glomerular disease in HIV and Hepatitis C co-infected patients in the era of HAART
  105. Pancreas–kidney transplantation is associated with reduced fracture risk compared with kidney-alone transplantation in men with type 1 diabetes
  106. Risk of Malignancy After Renal Transplantation
  107. Donor-Specific Antibodies Adversely Affect Kidney Allograft Outcomes
  108. Toxicokinetics of metformin-associated lactic acidosis with continuous renal replacement therapy
  109. Impact of Small Variations in the Delivered Dose of Rabbit Antithymocyte Induction Therapy in Kidney Transplantation With Early Corticosteroid Withdrawal
  110. Availability, Utilization and Outcomes of Deceased Diabetic Donor Kidneys; Analysis Based on the UNOS Registry
  111. Cost-effectiveness of Treating Chronic Anemia with Epoetin Alfa among Hemodialysis Patients in the United States
  112. Identifying Hemodialysis Catheter Recirculation Using Effective Ionic Dialysance
  113. Treatment of gabapentin-induced myoclonus with continuous renal replacement therapy
  114. Reduced Fracture Risk With Early Corticosteroid Withdrawal After Kidney Transplant
  115. Achieving the goal
  116. Early Improvement in Albuminuria in Non-diabetic Patients after Roux-en-Y Bariatric Surgery
  117. Urinary NGAL is a useful clinical biomarker of HIV-associated nephropathy
  118. Geographical variation in the response of lupus nephritis to mycophenolate mofetil induction therapy
  119. Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities
  120. Do meta-analyses in nephrology change the way we treat patients?
  121. Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease
  122. Effective Ionic Dialysance/Blood Flow Rate Ratio: An Indicator of Access Recirculation in Arteriovenous Fistulae
  123. 197: Renal Prognosis in HIV HCV Co-Infected Patients in the HAART ERA
  124. The Case ∣ 41-year-old HIV patient with proteinuria and progressive renal dysfunction
  125. Acute bilateral renal infarction secondary to cocaine-induced vasospasm
  126. Influence of concomitant prednisolone on trimethoprim-associated hyperkalaemia
  127. In Reply
  128. Hypokalemia During Sickle Cell Crises Apparently Due to Intermittent Mineralocorticoid Excess
  129. Proteinuria lowers the risk of amphotericin B-associated hypokalaemia
  130. 100
  131. SLEEP DISORDERS IN PATIENTS ON CHRONIC HEMODIALYSIS IN CENTRAL HARLEM
  132. Chyluria presenting as milky urine and nephrotic-range proteinuria
  133. A case of AIDS associated cryptococcal meningitis with multiple cranial nerve neuropathies
  134. Unusual Biopsy Findings in a Hepatitis C–Infected White Man With Cryoglobulinemia, Purpuric Rash, and Renal Failure
  135. Pneumocystosis Diagnosed by Bronchoalveolar Lavage in an Immunocompetent Polysubstance Abuser